In the “grandma gets scammed” comedy, June Squibb plays a 93-year-old who sends $10,000 in cash to con artists because she’s ...

Dividend investing has become increasingly popular over time, as generating regular income remains a key focus for investors.

As part of this shift in focus, Schwarzer stepped down as CEO, with Mary Beth Harler appointed as his replacement. Harler joined IGM in 2021 as president of autoimmunity and inflammation following an ...

IGM Biosciences ended last year laying off staff and streamlining its cancer pipeline. | IGM Biosciences ended last year ...

Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by ...

The new study included 82 patients whose large B-cell lymphoma had failed to respond to treatment or had returned after a ...

One of the first no-brainer dividend stocks to buy with $100 right now is AT&T. At recent prices, America's second-largest ...

The US FDA has approved a new drug, Cobenfy, for treating schizophrenia in adults. This is a first new class for medication ...

Prime Medicine said it will receive a $55 million upfront payment and a $55 million investment from Bristol Myers Squibb. It will is also eligible to receive more than $3.5 billion in milestones, ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

Mavacamten had been FDA approved on the basis of the EXPLORER-HCM trial's finding that the drug resulted in better functional ...